Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.
Wensi Zhao(Wuhan University), Ke‐Neng Chen(Peking University), Kangjian Deng(Guilin Medical University), Hao Fu(Peking University), Liang Dai(Peking University), Xiaozheng Kang(Peking University), Xingwang Xie(Peking University), Pu Chen(China Pharmaceutical University), Yongbo Yang(Chinese Academy of Agricultural Sciences), Hongsong Chen(Inner Mongolia University for Nationalities), Wanpu Yan(Peking University), Xueyan Wang(Hunan Normal University), Dongbo Chen(Diponegoro University)
PubMed
January 1, 2019
Cited by 31
Related Papers
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Whole-genome sequencing of six dog breeds from continuous altitudes reveals adaptation to high-altitude hypoxia
|Genome Research|2014|227
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192
Bioacoustic-enabled patterning of human iPSC-derived cardiomyocytes into 3D cardiac tissue
|Biomaterials|2017|123
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122